Chicago Partners Investment Group’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

Chicago Partners Investment Group’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-2,802	Closed	-$49K	–	620
2021 Q3	$49K	Buy	2,802 +1,034	+58%	+$30.8K	﹤0.01%	579
2021 Q2	$52K	Buy	+1,768	New	+$98.5K	﹤0.01%	528
2021 Q1	–	Sell	-1,386	Closed	-$82K	–	537
2020 Q4	$82K	Buy	+1,386	New	+$62.1K	0.01%	460

Other funds holding ORTX

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Chicago Partners Investment Group's ORTX Position: Q4 2021 in Review

Chicago Partners Investment Group sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q4 2021, closing a stake of 2,802 shares — an estimated $49K sold.

Chicago Partners Investment Group first reported a position in ORTX in Q4 2020 and held it in 3 quarters. The position peaked at $82K in Q4 2020. 72 funds tracked by Wall St. Rank hold ORTX as of Q4 2021.

Chicago Partners Investment Group reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q4 2021 after selling out during the quarter.
Chicago Partners Investment Group sold 2,802 Orchard Therapeutics plc American Depositary Shares shares in Q4 2021, an estimated $49K.
Chicago Partners Investment Group first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2020 and held it in 3 quarters.
Chicago Partners Investment Group's Orchard Therapeutics plc American Depositary Shares position peaked at $82K in Q4 2020.
72 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q4 2021.

Based on Chicago Partners Investment Group's 13F filing for Q4 2021, filed 15 Feb 2022.